Statistical Analysis. Data for most outcomes will be collected at baseline and during the performance of the metabolic study. Our general approach to address the specific and secondary aims is to develop an analysis of variance (ANOVA) model for each outcome of interest. Only losartan and NAC effects will be tested in these models, as a combined (losartan + NAC) treatment group is not proposed. Each outcome will have a different ANOVA model.